Claudio Rapezzi

37.5k total citations · 7 hit papers
366 papers, 15.4k citations indexed

About

Claudio Rapezzi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Claudio Rapezzi has authored 366 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Cardiology and Cardiovascular Medicine, 128 papers in Molecular Biology and 63 papers in Surgery. Recurrent topics in Claudio Rapezzi's work include Amyloidosis: Diagnosis, Treatment, Outcomes (113 papers), Cardiomyopathy and Myosin Studies (77 papers) and Cardiovascular Function and Risk Factors (62 papers). Claudio Rapezzi is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (113 papers), Cardiomyopathy and Myosin Studies (77 papers) and Cardiovascular Function and Risk Factors (62 papers). Claudio Rapezzi collaborates with scholars based in Italy, United States and United Kingdom. Claudio Rapezzi's co-authors include Perry Elliott, Elena Biagini, Angelo Branzi, Lorenzo Monserrat, William J. McKenna, Maria Letizia Bacchi Reggiani, Fabrizio Salvi, Ornella Leone, Candida Cristina Quarta and Luigi Tavazzi and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Claudio Rapezzi

360 papers receiving 15.0k citations

Hit Papers

Classification of the car... 2005 2026 2012 2019 2007 2013 2005 2013 2019 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
    2007 1.9k citations Claudio Rapezzi, Petar Seferović et al. European Heart Journal profile →
  2. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
    2013 737 citations Claudio Rapezzi, Elena Biagini et al. European Heart Journal profile →
  3. Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
    2005 607 citations Ornella Leone, Maria Letizia Bacchi Reggiani et al. profile →
  4. Guideline of transthyretin-related hereditary amyloidosis for clinicians
    2013 493 citations Laura Obici, Claudio Rapezzi et al. profile →
  5. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
    2019 331 citations Thibaud Damy, Sharmila Dorbala et al. profile →
  6. Long-Term Safety of Drug-Eluting and Bare-Metal Stents
    2015 326 citations Maria Letizia Bacchi Reggiani, Claudio Rapezzi et al. profile →
  7. RNA-targeting and gene editing therapies for transthyretin amyloidosis
    2022 120 citations Alberto Aimo, Vincenzo Castiglione et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Claudio Rapezzi 9.1k 6.9k 2.6k 2.3k 1.7k 366 15.4k
Stephen M. Schwartz 3.0k 0.3× 4.9k 0.7× 541 0.2× 4.2k 1.8× 914 0.5× 89 14.7k
Gianfranco Sinagra 11.7k 1.3× 4.8k 0.7× 351 0.1× 3.0k 1.3× 614 0.4× 679 17.3k
Yin Tintut 1.3k 0.1× 3.0k 0.4× 2.4k 0.9× 1.7k 0.7× 1.2k 0.7× 110 8.9k
Eloisa Arbustini 8.8k 1.0× 4.1k 0.6× 227 0.1× 3.8k 1.6× 734 0.4× 364 15.7k
Joseph J. Maleszewski 4.4k 0.5× 1.5k 0.2× 454 0.2× 1.7k 0.7× 1.0k 0.6× 234 7.6k
Justin C. Mason 1.1k 0.1× 3.9k 0.6× 988 0.4× 1.6k 0.7× 589 0.3× 213 10.6k
Agneta Siegbahn 5.9k 0.7× 3.5k 0.5× 169 0.1× 2.3k 1.0× 1.0k 0.6× 191 14.0k
Anthony J. Gill 1.2k 0.1× 4.5k 0.7× 1.1k 0.4× 4.3k 1.8× 5.7k 3.4× 535 16.9k
Geoffrey J. Gottlieb 4.9k 0.5× 2.8k 0.4× 495 0.2× 861 0.4× 1.2k 0.7× 28 10.6k
Matthew D. Griffin 775 0.1× 3.0k 0.4× 2.0k 0.8× 3.0k 1.3× 1.5k 0.9× 204 12.7k

Countries citing papers authored by Claudio Rapezzi

Since Specialization
Citations

This map shows the geographic impact of Claudio Rapezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Rapezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Rapezzi more than expected).

Fields of papers citing papers by Claudio Rapezzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Rapezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Rapezzi. The network helps show where Claudio Rapezzi may publish in the future.

Co-authorship network of co-authors of Claudio Rapezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Rapezzi. A scholar is included among the top collaborators of Claudio Rapezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Rapezzi. Claudio Rapezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brito, Dulce, Diego Pérez de Arenaza, N. Bart, et al.. (2023). World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM). Global Heart. 18(1). 59–59. 33 indexed citations
2.
Leone, Ornella, Valentina Agostini, Maddalena Graziosi, et al.. (2022). La morte improvvisa giovanile e in età adulta: cause e concause. L’esperienza della rete multidisciplinare in Emilia-Romagna. Giornale italiano di cardiologia. 23(3). 200–210. 4 indexed citations
3.
Olivotto, Iacopo, James E. Udelson, Maurizio Pieroni, & Claudio Rapezzi. (2022). Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments. European Heart Journal. 44(8). 656–667. 20 indexed citations
4.
Rapezzi, Claudio, Alberto Aimo, Andrea Barison, et al.. (2022). Restrictive cardiomyopathy: definition and diagnosis. European Heart Journal. 43(45). 4679–4693. 90 indexed citations
5.
Rapezzi, Claudio. (2021). EXPLORER-HCM: il mavacamten nel trattamento della cardiomiopatia ipertrofica ostruttiva sintomatica. Giornale italiano di cardiologia. 22(1). 30–32. 1 indexed citations
6.
Quarta, Candida Cristina, David F. Hutt, Richa Manwani, et al.. (2021). 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 22(11). 1304–1311. 42 indexed citations
7.
Balla, Cristina, Rita Selvatici, Paola Imbrici, et al.. (2021). Mutations in MYBPC3 and MYH7 in Association with Brugada Type 1 ECG Pattern: Overlap between Brugada Syndrome and Hypertrophic Cardiomyopathy?. SHILAP Revista de lepidopterología. 11(3). 139–147. 5 indexed citations
8.
Balla, Cristina, Cecilia Trabanelli, Luca Ragni, et al.. (2021). Left Ventricular Myocardial Noncompaction with Advanced Atrioventricular Conduction Disorder and Ventricular Arrhythmias in a Young Patient: Role of MIB1 Gene. Journal of Cardiovascular Development and Disease. 8(9). 109–109. 4 indexed citations
9.
Pucci, Angela, Alberto Aimo, Veronica Musetti, et al.. (2021). Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis. Journal of the American Heart Association. 10(20). e020358–e020358. 69 indexed citations
10.
Emdin, Michele, Alberto Aimo, Claudio Rapezzi, et al.. (2019). Treatment of cardiac transthyretin amyloidosis: an update. European Heart Journal. 40(45). 3699–3706. 111 indexed citations
11.
Conti, Matteo, Elena Zamagni, Ornella Leone, et al.. (2018). A targeted proteomics approach to amyloidosis typing. PubMed. 7. 18–28. 4 indexed citations
12.
Russo, Pierluigi, Generoso Andria, Roberto Della Casa, et al.. (2017). Il cardiologo e le mucopolisaccaridosi. Raccomandazioni del GICEM (Gruppo Italiano Cardiologi Esperti Malattie Metaboliche) su diagnosi, follow-up e management cardiologico. Giornale italiano di cardiologia. 18(9). 638–649. 5 indexed citations
13.
Dall’Ara, Gianni, Antonío Marzocchi, Nevio Taglieri, et al.. (2017). Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study. Journal of Interventional Cardiology. 31(1). 51–59. 6 indexed citations
14.
Dall’Ara, Gianni, Andrea Santarelli, Antonío Marzocchi, et al.. (2017). Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices. Catheterization and Cardiovascular Interventions. 91(6). E49–E55. 10 indexed citations
15.
Corsini, Anna, Massimiliano Lorenzini, Davide Pacini, et al.. (2015). Acute Heart Failure in Patients with Acute Aortic Syndrome: Pathophysiology and Clinical–Prognostic Implications. European Journal of Heart Failure. 17(9). 917–924. 9 indexed citations
16.
Longhi, Simone, Christian Gagliardi, Agnese Milandri, Lisa Manuzzi, & Claudio Rapezzi. (2014). La cardiomiopatia amiloidotica correlata alla transtiretina: alla ricerca del trattamento eziologico. Giornale italiano di cardiologia. 15(5). 293–300. 2 indexed citations
17.
Taglieri, Nevio, Paolo Ortolani, Maria Letizia Bacchi Reggiani, et al.. (2014). Long-Term Outcomes and Causes of Death After Acute Coronary Syndrome in Patients in the Bologna, Italy, Area. The American Journal of Cardiology. 115(2). 171–177. 14 indexed citations
18.
d’Amati, Giulia, Ornella Leone, Stefano Nistri, et al.. (2013). Cambi di paradigma in tema di aorta: implicazioni cliniche e terapeutiche La biopatologia dell’aorta. Giornale italiano di cardiologia. 14(2). 97–109. 2 indexed citations
19.
Bronzetti, Gabriele, et al.. (2012). Sempre oscura mi fu quest’aVR. L’insospettabile ricchezza di una derivazione dimenticata. Giornale italiano di cardiologia. 13(9). 602–6. 3 indexed citations
20.
Capucci, Alessandro, Federico Guerra, Roberto Antonicelli, et al.. (2012). Dronedarone: una reale innovazione o solo una valida seconda scelta? Come districarsi tra linee guida, agenzie regolatorie e pratica clinica quotidiana. Giornale italiano di cardiologia. 13(5). 326–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen M. Schwartz Breakdown of academic impact, for papers by Gianfranco Sinagra Breakdown of academic impact, for papers by Yin Tintut Breakdown of academic impact, for papers by Eloisa Arbustini Breakdown of academic impact, for papers by Joseph J. Maleszewski Breakdown of academic impact, for papers by Justin C. Mason Breakdown of academic impact, for papers by Agneta Siegbahn Breakdown of academic impact, for papers by Anthony J. Gill Breakdown of academic impact, for papers by Geoffrey J. Gottlieb Breakdown of academic impact, for papers by Matthew D. Griffin
Rankless by CCL
2026